Drug Safety

A Benefit-Risk Assessment of Erlotinib in Non-Small-Cell Lung Cancer and Pancreatic Cancer
pp. 175-186(12)
Authors: Mountzios, Giannis; Syrigos, Kostas N.

Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to?: A Review of the New EU Legislation on Pharmacovigilance
pp. 187-197(11)
Authors: Borg, John-Joseph; Aislaitner, George; Pirozynski, Michal; Mifsud, Stephen

Safety of Nortriptyline at Equivalent Therapeutic Doses for Smoking Cessation: A Systematic Review and Meta-Analysis
pp. 199-210(12)
Authors: Dhippayom, Teerapon; Chaiyakunapruk, Nathorn; Jongchansittho, Thitima

Parental Reporting of Adverse Drug Reactions Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Medications in Children Attending Specialist Paediatric Clinics in the UK
pp. 211-219(9)
Authors: Tobaiqy, Mansour; Stewart, Derek; Helms, Peter J.; Williams, Justin; Crum, Jackie; Steer, Christopher; McLay, James

Intensive Monitoring of Pregabalin: Results from an Observational, Web-Based, Prospective Cohort Study in the Netherlands Using Patients as a Source of Information
pp. 221-231(11)
Authors: Härmark, Linda; >Eugène van Puijenbroek,; Straus, Sabine; >Kees van Grootheest,

A Computerized Adverse Drug Event Alerting System Using Clinical Rules: A Retrospective and Prospective Comparison with Conventional Medication Surveillance in the Netherlands
pp. 233-242(10)
Authors: Rommers, Mirjam K.; Teepe-Twiss, Irene M.; Guchelaar, Henk-Jan

Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH): Application of this Data Organization Approach to Phase III Clinical Trials of Rivaroxaban after Total Hip or Knee Replacement Surgery
pp. 243-252(10)
Authors: Watkins, Paul B.; Desai, Mehul; Berkowitz, Scott D.; Peters, Gary; Horsmans, Yves; Larrey, Dominique; Maddrey, Willis

Reporting Patterns Indicative of Adverse Drug Interactions: A Systematic Evaluation in VigiBase
pp. 253-266(14)
Authors: Strandell, Johanna; Caster, Ola; Bate, Andrew; Norén, Niklas; Edwards, I. Ralph